Cargando…

Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021

Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage...

Descripción completa

Detalles Bibliográficos
Autores principales: Faye, Martin, Kébé, Ousmane, Diop, Boly, Ndiaye, NDack, Dosseh, Annick, Sam, Abdoulaye, Diallo, Aliou, Dia, Hamet, Diallo, Jean Pierre, Dia, Ndongo, Kiori, Davy Evrard, Diop, Ousmane Madiagne, Sall, Amadou Alpha, Faye, Ousmane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514370/
https://www.ncbi.nlm.nih.gov/pubmed/36148906
http://dx.doi.org/10.3201/eid2810.220847
_version_ 1784798260395769856
author Faye, Martin
Kébé, Ousmane
Diop, Boly
Ndiaye, NDack
Dosseh, Annick
Sam, Abdoulaye
Diallo, Aliou
Dia, Hamet
Diallo, Jean Pierre
Dia, Ndongo
Kiori, Davy Evrard
Diop, Ousmane Madiagne
Sall, Amadou Alpha
Faye, Ousmane
author_facet Faye, Martin
Kébé, Ousmane
Diop, Boly
Ndiaye, NDack
Dosseh, Annick
Sam, Abdoulaye
Diallo, Aliou
Dia, Hamet
Diallo, Jean Pierre
Dia, Ndongo
Kiori, Davy Evrard
Diop, Ousmane Madiagne
Sall, Amadou Alpha
Faye, Ousmane
author_sort Faye, Martin
collection PubMed
description Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage samples from 2 sites in Dakar monthly for polioviruses. We identified a vaccine-derived poliovirus serotype 2 on January 19, 2021, from a sample collected on December 24, 2020; by December 31, 2021, we had detected 70 vaccine-derived poliovirus serotype 2 isolates circulating in 7 of 14 regions in Senegal. Sources included 18 AFP cases, 20 direct contacts, 17 contacts in the community, and 15 sewage samples. Phylogenetic analysis revealed the circulation of 2 clusters and provided evidence on the virus introduction from Guinea. Because novel oral polio vaccine serotype 2 was used for response activities throughout Senegal, we recommend expanding environmental surveillance into other regions.
format Online
Article
Text
id pubmed-9514370
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-95143702022-10-01 Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 Faye, Martin Kébé, Ousmane Diop, Boly Ndiaye, NDack Dosseh, Annick Sam, Abdoulaye Diallo, Aliou Dia, Hamet Diallo, Jean Pierre Dia, Ndongo Kiori, Davy Evrard Diop, Ousmane Madiagne Sall, Amadou Alpha Faye, Ousmane Emerg Infect Dis Research Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage samples from 2 sites in Dakar monthly for polioviruses. We identified a vaccine-derived poliovirus serotype 2 on January 19, 2021, from a sample collected on December 24, 2020; by December 31, 2021, we had detected 70 vaccine-derived poliovirus serotype 2 isolates circulating in 7 of 14 regions in Senegal. Sources included 18 AFP cases, 20 direct contacts, 17 contacts in the community, and 15 sewage samples. Phylogenetic analysis revealed the circulation of 2 clusters and provided evidence on the virus introduction from Guinea. Because novel oral polio vaccine serotype 2 was used for response activities throughout Senegal, we recommend expanding environmental surveillance into other regions. Centers for Disease Control and Prevention 2022-10 /pmc/articles/PMC9514370/ /pubmed/36148906 http://dx.doi.org/10.3201/eid2810.220847 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Faye, Martin
Kébé, Ousmane
Diop, Boly
Ndiaye, NDack
Dosseh, Annick
Sam, Abdoulaye
Diallo, Aliou
Dia, Hamet
Diallo, Jean Pierre
Dia, Ndongo
Kiori, Davy Evrard
Diop, Ousmane Madiagne
Sall, Amadou Alpha
Faye, Ousmane
Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
title Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
title_full Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
title_fullStr Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
title_full_unstemmed Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
title_short Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
title_sort importation and circulation of vaccine-derived poliovirus serotype 2, senegal, 2020–2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514370/
https://www.ncbi.nlm.nih.gov/pubmed/36148906
http://dx.doi.org/10.3201/eid2810.220847
work_keys_str_mv AT fayemartin importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT kebeousmane importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT diopboly importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT ndiayendack importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT dossehannick importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT samabdoulaye importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT dialloaliou importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT diahamet importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT diallojeanpierre importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT diandongo importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT kioridavyevrard importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT diopousmanemadiagne importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT sallamadoualpha importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021
AT fayeousmane importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021